Table 5.
Pooled Population (n = 92) | ||
---|---|---|
Events, n | Patients, n (%) | |
Any adverse event | 30 | 22 (23.9) |
Serious adverse event | 0 | 0 |
Severe adverse event | 0 | 0 |
Adverse events by treatment received | ||
OnabotulinumtoxinA | 15 | 12 (13.0) |
IncobotulinumtoxinA | 15 | 13 (14.1) |
Adverse events by underlying condition | ||
Cervical dystonia (n = 58) | 17 | 12 (20.7) |
Blepharospasm (n = 34) | 13 | 10 (29.4) |